How big is the Europe Cancer Therapeutics Market?

The Europe Cancer Therapeutics Market size is expected to reach USD 58.32 billion in 2024 and grow at a CAGR of 5.38% to reach USD 75.79 billion by 2029. Read More

What is the current Europe Cancer Therapeutics Market size?

In 2024, the Europe Cancer Therapeutics Market size is expected to reach USD 58.32 billion. Read More

Who are the key players in Europe Cancer Therapeutics Market?

Amgen Inc., AstraZeneca PLC, Bayer AG, Bristol-Meyrs Squibb Company and F. Hoffmann-La Roche Ltd are the major companies operating in the Europe Cancer Therapeutics Market. Read More

What years does this Europe Cancer Therapeutics Market cover, and what was the market size in 2023?

In 2023, the Europe Cancer Therapeutics Market size was estimated at USD 55.34 billion. The report covers the Europe Cancer Therapeutics Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Europe Cancer Therapeutics Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Europe Cancer Therapeutics Market Report | Industry Analysis, Size & Forecast

Europe Cancer Therapeutics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The report covers Europe Cancer Biological Therapy Market Growth and the market is segmented into By Treatment Type (Chemotherapy, Target Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy, Other Treatment Types), Cancer Type (Blood Cancer, Breast Cancer, Prostate Cancer, Gastrointestinal Cancer, Gynecologic Cancer, Respiratory/Lung Cancer, Other Cancer Types), By End-Users (Hospitals, Specialty Clinics, Cancer and Radiation Therapy Centers), and Geography (Germany, United Kingdom, France, Italy, Spain, Rest of Europe). The market provides the value (in USD million) for the above-mentioned segments.

Europe Cancer Therapeutics Industry Overview

The Europe cancer therapeutics market is fragmented in nature due to the presence of fewer companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international as well as local companies which hold the market shares and are well known as Amgen Inc., AstraZeneca PLC, Bayer AG, Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline PLC, Johnson & Johnson, Merck & Co. Inc., Novartis AG, and Pfizer Inc.